Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy?

The company is hoping to expand, but is there enough here to attract growth investors?Johnson & Johnson (JNJ 0.46%) has focused more on growth initiatives since spinning off its consumer healthcare business into what is now Kenvue. In 2022, it made a big move with the acquisition of heart pump maker Abiomed for a whopping $16.6 billion. And recently, J&J announced yet another major deal: It is acquiring Shockwave Medical (SWAV 0.54%) for $13.1 billion.What does this mean for the company, and does this move ...